Question 1

What is Altimmune?

Accepted Answer

Altimmune is a Company.

Question 2

How often does Altimmune appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was Altimmune first tracked by Ergen?

Accepted Answer

First tracked on Aug 06, 2025.

Question 4

When was Altimmune last mentioned in news?

Accepted Answer

Last active on May 28, 2026.

Question 5

What is Altimmune's current news sentiment?

Accepted Answer

Aggregate sentiment score: -80 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Altimmune in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Altimmune?

Accepted Answer

Altimmune Class Action Lawsuit Filed (Aug 06, 2025, 6 articles).

Question 8

How did the "Altimmune Class Action Lawsuit Filed" event impact Altimmune?

Accepted Answer

Altimmune is facing a federal securities class action lawsuit after its stock price declined dramatically following the announcement of disappointing Phase 2b MASH trial results for Pemvidutide.

Question 9

How did the "Altimmune Class Action Lawsuit Filed" event impact Altimmune?

Accepted Answer

Altimmune is the defendant in a class action lawsuit due to alleged securities fraud related to misleading statements about its IMPACT Phase 2b MASH trial results, which caused a significant drop in its stock price.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.